These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 26836368)

  • 1. Improving the solubility of dexlansoprazole by cocrystallization with isonicotinamide.
    Li J; Wang L; Ye YQ; Fu X; Ren Q; Zhang H; Deng Z
    Eur J Pharm Sci; 2016 Mar; 85():47-52. PubMed ID: 26836368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol cocrystals with enhanced solubility and tabletability.
    Zhou Z; Li W; Sun WJ; Lu T; Tong HHY; Sun CC; Zheng Y
    Int J Pharm; 2016 Jul; 509(1-2):391-399. PubMed ID: 27282539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
    Boksa K; Otte A; Pinal R
    J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocrystals of diacerein: Towards the development of improved biopharmaceutical parameters.
    Tomar S; Chakraborti S; Jindal A; Grewal MK; Chadha R
    Int J Pharm; 2020 Jan; 574():118942. PubMed ID: 31830577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
    Ober CA; Gupta RB
    AAPS PharmSciTech; 2012 Dec; 13(4):1396-406. PubMed ID: 23054991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing the Pharmaceutical Behavior of Nateglinide by Cocrystallization: Physicochemical Assessment of Cocrystal Formation and Informed Use of Differential Scanning Calorimetry for Its Quantitative Characterization.
    Bruni G; Maggi L; Mustarelli P; Sakaj M; Friuli V; Ferrara C; Berbenni V; Girella A; Milanese C; Marini A
    J Pharm Sci; 2019 Apr; 108(4):1529-1539. PubMed ID: 30476510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Ferulic Acid-Nicotinamide Cocrystal With Improved Solubility and Dissolution Performance.
    Chaves Júnior JV; Dos Santos JAB; Lins TB; de Araújo Batista RS; de Lima Neto SA; de Santana Oliveira A; Nogueira FHA; Gomes APB; de Sousa DP; de Souza FS; Aragão CFS
    J Pharm Sci; 2020 Mar; 109(3):1330-1337. PubMed ID: 31821823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties.
    Emami S; Adibkia K; Barzegar-Jalali M; Siahi-Shadbad M
    Pharm Dev Technol; 2019 Feb; 24(2):199-210. PubMed ID: 29557714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel furosemide cocrystals and selection of high solubility drug forms.
    Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
    J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chrysin cocrystals: Characterization and evaluation.
    Chadha R; Bhalla Y; Nandan A; Chadha K; Karan M
    J Pharm Biomed Anal; 2017 Feb; 134():361-371. PubMed ID: 27894779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
    Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
    Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
    Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Binary System of Ibuprofen-Nicotinamide Under Nanoscale Confinement: From Cocrystal to Coamorphous State.
    Bi Y; Xiao D; Ren S; Bi S; Wang J; Li F
    J Pharm Sci; 2017 Oct; 106(10):3150-3155. PubMed ID: 28625724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental and DFT simulation study of a novel felodipine cocrystal: Characterization, dissolving properties and thermal decomposition kinetics.
    Yang C; Guo W; Lin Y; Lin Q; Wang J; Wang J; Zeng Y
    J Pharm Biomed Anal; 2018 May; 154():198-206. PubMed ID: 29550709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide.
    Chow SF; Chen M; Shi L; Chow AH; Sun CC
    Pharm Res; 2012 Jul; 29(7):1854-65. PubMed ID: 22359146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of a Glibenclamide Cocrystal: Full Spectroscopic and Thermal Characterization.
    Silva Filho SF; Pereira AC; Sarraguça JMG; Sarraguça MC; Lopes J; Façanha Filho PF; Dos Santos AO; da Silva Ribeiro PR
    J Pharm Sci; 2018 Jun; 107(6):1597-1604. PubMed ID: 29432762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals.
    Soares FL; Carneiro RL
    J Pharm Biomed Anal; 2014 Feb; 89():166-75. PubMed ID: 24291798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
    Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
    J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dry Mechanochemical Synthesis of Caffeine/Oxalic Acid Cocrystals and Their Evaluation by Powder X-Ray Diffraction and Chemometrics.
    Otsuka Y; Ito A; Takeuchi M; Tanaka H
    J Pharm Sci; 2017 Dec; 106(12):3458-3464. PubMed ID: 28797789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.